Navigation Links
BioDelivery Sciences Provides Update on Ongoing Phase 3 Pivotal Trial for Clonidine Topical Gel for Painful Diabetic Neuropathy
Date:8/6/2014

tain the probability of a successful outcome," said Dr. Mark A. Sirgo, President and Chief Executive Officer. "Based on this information we will continue to progress other aspects of the clinical development program necessary for the NDA."

About BioDelivery Sciences International

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine.  BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.

BDSI's development strategy focuses on utilization of the FDA's 505(b)(2) approval process. This regulatory pathway creates the potential for more timely and efficient approval of new formulations of previously approved therapeutics.

BDSI's particular area of focus is the development and commercialization of products in the areas of pain management and addiction. These are areas where BDSI believes its drug delivery technologies and products can best be applied to address critical unmet medical needs.  BDSI's marketed products and those in development address serious and debilitating conditions such as breakthrough cancer pain, chronic pain, painful diabetic neuropathy and opioid dependence.

BDSI's headquarters is located in Raleigh, North Carolina. 

For more information visit www.bdsi.com.

BDSI can now be followed on Facebook (Facebook.com/BioDeliverySI) and Twitter (Twitter.com/BioDeliverySI)


'/>"/>
SOURCE BioDelivery Sciences International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
2. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
3. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
4. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
5. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
6. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
7. BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations
8. BioDelivery Sciences to Present at the 24th Annual Piper Jaffray Healthcare Conference
9. BioDelivery Sciences Announces $40 Million Registered Financing
10. BioDelivery Sciences Announces Completion of BNX Safety Study
11. BioDelivery Sciences to Present at the 15th Annual BIO CEO and Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 More than ... the country will convene in Indianapolis ... (CADCA),s 2015 Mid-Year Training Institute . The week-long ... how to address one of our nation,s biggest public ... CADCA,s Mid-Year Training Institute is a one-of-a-kind intensive training ...
(Date:7/31/2015)... , July 31, 2015 ... Review, 2015 market research report that provides an ... stage using data sourced from in-house databases, secondary ... syringes and needles market products pipeline spread across ... supported with 73 tables and 5 figures is ...
(Date:7/31/2015)... BOSTON , July 31, 2015  Boston ... children benefiting from 3D printing of their anatomy ... had life-threatening cerebrovascular malformations (abnormalities in the brain,s ... Reporting online today in the Journal ... use of 3D printing and synthetic resins to ...
Breaking Medicine Technology:Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 2Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 53D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4
... Inc. (NYSE Amex: ANX ) today announced ... acquire SynthRx, Inc. (SynthRx), a private biotechnology company developing ... poloxamer 188 (188). "The acquisition of ... another late-stage asset to our pipeline," stated Brian M. ...
... SANTA CLARA, Calif., Feb. 13, 2011 Samplify ... and sub-systems for the ultrasound equipment market, announced ... company as Senior Scientist, where he will apply ... its next generation of ultrasound beamforming technology and ...
Cached Medicine Technology:ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc. 2ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc. 3ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc. 4ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc. 5ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc. 6Ultrasound Industry Expert, Chris Daft, Joins Samplify Systems 2
(Date:8/3/2015)... ... August 03, 2015 , ... As reported in a ... series, “Atlanta Plastic” is getting attention for moving outside traditional ethnic stereotypes when ... African-American cast of doctors and patients. Beverly Hills based plastic surgeon Payam Jarrah-Nejad, ...
(Date:8/3/2015)... ... August 03, 2015 , ... BESLER Consulting today ... B2B Awards. , The MarketingProfs Bright Bulb B2B Awards celebrate the best marketing, ... for the launch of their Readmissions Analytics product was selected as one of ...
(Date:8/3/2015)... ... August 03, 2015 , ... Catalent Pharma Solutions, the ... and consumer health products, today welcomed the announcement by OPKO Health that the ... for a new treatment for chronic kidney disease (CKD) and vitamin D insufficiency, ...
(Date:8/3/2015)... ... August 03, 2015 , ... The art of preparing and ... her grandmother’s side at a young age, Nasreen Zereshki was extremely eager to cook ... share her cookbook Recipes from My Persian Kitchen with the world. , Since Americans ...
(Date:8/3/2015)... ... 2015 , ... The U.S. Food and Drug Administration (FDA) recently approved a ... acid, which occurs naturally in the body and helps absorb and breakdown fat cells. ... the body. These are invasive procedures and very expensive for most people. Now with ...
Breaking Medicine News(10 mins):Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3
... Ex-police officer and certified search & rescue manager won contest to ... , LOS ANGELES, June 17 Can ... of the late search and rescue dog and 9-11 hero, Trakr, ... 2009. BioArts International, a Northern California biotech company that is offering ...
... ... ... -- The IMTA and PATA recently signed a Memorandum of Understanding (MOU) to promote healthcare ... development of this high value sector and drive more integration between the travel and healthcare ...
... ... practice to a brand new state of the art location at 5044 Tennyson in Plano. ... Laser Surgery. , ... 2009 -- Dr. Bryan Selkin, the Chief Dermatologist of the Dermatology Center of Plano will be ...
... Two Cold Remedy Nasal Products Citing Commitment to Consumer Safety ... Matrixx Initiatives, Inc. (Nasdaq: MTXX ) has confirmed ... Food and Drug Administration about two of its 19 existing ... Cold Remedy Swabs. The warning letter cited consumer reports that ...
... June 16 Mammography has long been the standard for ... tissue can make tumors difficult to find. According to ... tissue are five times more likely to develop breast cancer. ... SI ) at: http://inr.mediaseed.tv/oneClip_C/?feed=KmAdskkAWyriUTQcX9fLjuG_zA0wEhsO ...
... PHILADELPHIA, June 16 United States Attorney Michael L. ... today announced the return of an indictment(1.) against Norian ... executives, Michael D. Huggins (Huggins), Thomas B. Higgins (Higgins), ... charging them for their involvement in conducting clinical trials ...
Cached Medicine News:Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 2Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 3Health News:The International Medical Travel Association (IMTA) and Pacific Asia Travel Association (PATA) sign MOU to Promote Healthcare Travel 2Health News:The International Medical Travel Association (IMTA) and Pacific Asia Travel Association (PATA) sign MOU to Promote Healthcare Travel 3Health News:New State of the Art Dermatology Center in Plano TX 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 3Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 2Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 3Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 4Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 5Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 6Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 7
... has greatly enhanced the stabilization ... Biomet Low Profile Tibial Nail ... treatment of unstable fractures, tibial ... pathologic or impending fractures but ...
Arthroscopic instrument system for instability and SLAP fixation....
Arthroscopic instrument system for instability and SLAP fixation....
Suture Cutter, Open Ended, Left Notch...
Medicine Products: